Lianqun Cui Selected Research

Lianqun Cui Research Topics

Disease

11	Coronary Artery Disease (Coronary Atherosclerosis) 02/2019 - 11/2011
8	Atherosclerosis 07/2022 - 12/2011
8	Myocardial Infarction 01/2018 - 12/2011
5	Acute Coronary Syndrome 01/2022 - 03/2010
4	Cardiovascular Diseases (Cardiovascular Disease) 07/2022 - 11/2011
4	Heart Failure 03/2022 - 08/2013
4	Hyperlipidemias (Hyperlipidemia) 08/2021 - 01/2015
4	Atherosclerotic Plaque (Atheroma) 08/2021 - 12/2010
3	Fibrosis (Cirrhosis) 11/2017 - 08/2013
3	Inflammation (Inflammations) 10/2017 - 08/2008
2	Infarction (Infarctions) 04/2021 - 10/2017
2	Hypertension (High Blood Pressure) 01/2021 - 01/2016
2	Type 2 Diabetes Mellitus (MODY) 10/2014 - 05/2013
1	Ventricular Tachycardia 04/2021
1	Headache (Headaches) 01/2021
1	Edema (Dropsy) 01/2021
1	Essential Hypertension 01/2021
1	Hypoxia (Hypoxemia) 12/2019
1	Stable Angina 12/2019
1	Diabetes Mellitus 12/2017
1	Carotid Artery Diseases 12/2017
1	Thrombosis (Thrombus) 11/2017
1	Necrosis 10/2017
1	Neoplasms (Cancer) 10/2017
1	Hypertrophy 08/2017
1	Death (Near-Death Experience) 01/2017
1	Hypercholesterolemia 01/2015
1	Coronary Disease (Coronary Heart Disease) 07/2009
1	Hyperplasia 08/2008

Drug/Important Bio-Agent (IBA)

6	oxidized low density lipoproteinIBA 07/2022 - 01/2015
6	Proteins (Proteins, Gene)FDA Link 04/2021 - 08/2016
3	erucylphosphocholineIBA 07/2022 - 01/2015
3	LipidsIBA 08/2021 - 10/2014
2	CytokinesIBA 07/2022 - 08/2021
2	GhrelinIBA 03/2022 - 12/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2021 - 01/2015
2	Biomarkers (Surrogate Marker)IBA 12/2019 - 01/2015
2	Carrier Proteins (Binding Protein)IBA 02/2019 - 12/2017
2	LDL Lipoproteins (beta Lipoproteins)IBA 10/2018 - 11/2015
2	C-Reactive ProteinIBA 01/2018 - 12/2010
2	Cathepsin BIBA 11/2017 - 08/2013
2	CalciumIBA 08/2017 - 07/2009
2	omega-Chloroacetophenone (Mace)IBA 01/2017 - 11/2011
2	Glipizide (Glucotrol)FDA LinkGeneric 10/2014 - 05/2013
2	Metformin (Glucophage)FDA LinkGeneric 10/2014 - 05/2013
2	Metalloproteases (Metalloproteinases)IBA 12/2011 - 03/2010
2	DisintegrinsIBA 12/2011 - 03/2010
1	Oxygen (Dioxygen)IBA 07/2022
1	Particulate MatterIBA 07/2022
1	Cysteine (L-Cysteine)FDA Link 07/2022
1	Plasma GasesIBA 01/2022
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2022
1	Platelet Endothelial Cell Adhesion Molecule-1IBA 04/2021
1	Small Interfering RNA (siRNA)IBA 04/2021
1	Amlodipine (Norvasc)FDA LinkGeneric 01/2021
1	maleic acid (maleate)IBA 01/2021
1	S- (2- chloro- 1,1,2- trifluoroethyl)cysteine (CTFC)IBA 01/2018
1	MB Form Creatine KinaseIBA 01/2018
1	Troponin IIBA 01/2018
1	Macrophage Migration-Inhibitory FactorsIBA 01/2018
1	Circular RNAIBA 12/2017
1	Glucose (Dextrose)FDA LinkGeneric 12/2017
1	Glycoproteins (Glycoprotein)IBA 12/2017
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2017
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 10/2017
1	EnzymesIBA 10/2017
1	DiminazeneIBA 10/2017
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 10/2017
1	Casein Kinases (Casein Kinase)IBA 10/2017
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 10/2017
1	Lipoprotein(a)IBA 01/2017
1	Antihypertensive Agents (Antihypertensives)IBA 01/2016
1	pitavastatin (itavastatin)FDA Link 01/2015
1	Simvastatin (Zocor)FDA LinkGeneric 01/2015
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 10/2014
1	Therapeutic UsesIBA 10/2014
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 10/2014
1	Aldehyde DehydrogenaseIBA 10/2014
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 09/2013
1	CA 074 methyl esterIBA 08/2013
1	CathepsinsIBA 08/2013
1	Peptide Hydrolases (Proteases)FDA Link 12/2011
1	ThrombospondinsIBA 03/2010
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 08/2008

Therapy/Procedure

2	Stents 11/2017 - 06/2014
2	Percutaneous Coronary Intervention 11/2017 - 11/2011
1	Aftercare (After-Treatment) 01/2018
1	Patient Readmission 06/2014
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 06/2014
1	Replantation 06/2014
1	Drug-Eluting Stents 11/2011